[go: up one dir, main page]

CY1114888T1 - Προϊον για τη θεραπεια του δερματος και των βλεννογονων μεμβρανων, καθως και σχετικη μεθοδος παρασκευης - Google Patents

Προϊον για τη θεραπεια του δερματος και των βλεννογονων μεμβρανων, καθως και σχετικη μεθοδος παρασκευης

Info

Publication number
CY1114888T1
CY1114888T1 CY20141100055T CY141100055T CY1114888T1 CY 1114888 T1 CY1114888 T1 CY 1114888T1 CY 20141100055 T CY20141100055 T CY 20141100055T CY 141100055 T CY141100055 T CY 141100055T CY 1114888 T1 CY1114888 T1 CY 1114888T1
Authority
CY
Cyprus
Prior art keywords
trichloroacetic acid
treatment
product
mixture
leather
Prior art date
Application number
CY20141100055T
Other languages
English (en)
Inventor
Rossana Castellana
Original Assignee
Rossana Castellana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36658741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114888(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rossana Castellana filed Critical Rossana Castellana
Publication of CY1114888T1 publication Critical patent/CY1114888T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μέθοδος για την παρασκευή ενός προϊόντος νια τη θεραπεία του δέρματος και των βλεννογόνων μεμβρανών περιλαμβάνει τις βαθμίδες του να γίνει διαθέσιμη μια κατάλληλη ποσότητα τριχλωροοξικού οξέος, να γίνει διαθέσιμη μια κατάλληλη ποσότητα υπεροξειδίου υδρογόνου, να κατασκευαστεί ένα πρώτο μίγμα του τριχλωροοξικού οξέος και του υπεροξειδίου υδρογόνου, να γίνει διαθέσιμη μια καθορισμένη ποσότητα της βασικής ένωσης και να επιτευχθεί ένα ρυθμιστικό αποτέλεσμα του τριχλωροοξικού οξέος που περιλαμβάνεται στο πρώτο μίγμα, καθώς και να προστεθεί η βασική ένωση στο πρώτο μίγμα προκειμένου να ρυθμιστεί το πρώτο μίγμα που περιλαμβάνει το τριχλωροοξικό οξύ.
CY20141100055T 2005-12-13 2014-01-22 Προϊον για τη θεραπεια του δερματος και των βλεννογονων μεμβρανων, καθως και σχετικη μεθοδος παρασκευης CY1114888T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000211A ITUD20050211A1 (it) 2005-12-13 2005-12-13 Prodotto per il trattamento della pelle relativo procedimento di preparazione
EP06831681.9A EP1979053B1 (en) 2005-12-13 2006-12-12 Product for treating the skin and mucous membranes, and relative method of preparation

Publications (1)

Publication Number Publication Date
CY1114888T1 true CY1114888T1 (el) 2016-12-14

Family

ID=36658741

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100055T CY1114888T1 (el) 2005-12-13 2014-01-22 Προϊον για τη θεραπεια του δερματος και των βλεννογονων μεμβρανων, καθως και σχετικη μεθοδος παρασκευης

Country Status (13)

Country Link
US (1) US10874883B2 (el)
EP (1) EP1979053B1 (el)
JP (1) JP5344926B2 (el)
AU (1) AU2006325083B2 (el)
CY (1) CY1114888T1 (el)
DK (1) DK1979053T3 (el)
ES (1) ES2441440T3 (el)
HR (1) HRP20140063T1 (el)
IT (1) ITUD20050211A1 (el)
PL (1) PL1979053T3 (el)
PT (1) PT1979053E (el)
SI (1) SI1979053T1 (el)
WO (1) WO2007069024A2 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2930727B1 (fr) * 2008-04-30 2012-10-05 Evolution Dermatologique Lab Composition pour le traitement des etats seborrheiques.
ES2758349T3 (es) * 2010-07-15 2020-05-05 Progressare Medinvest B V Composición para el tratamiento de lesiones de la piel y/o de las uñas
IT201600111171A1 (it) * 2016-11-04 2018-05-04 Uras Cosmetics S R L S Kit per il trattamento della pelle e suo impiego
IT201700104536A1 (it) * 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
CN114096226A (zh) * 2019-06-24 2022-02-25 罗萨纳·卡斯特拉纳 用于牙科学和皮肤病学用途的含有三氯乙酸盐和羟基羧酸的制剂
CA3200316A1 (en) 2020-12-01 2022-06-09 Rossana Castellana Formulations for healing of traumatic lesions of the skin and mucous membranes
IT202200025614A1 (it) * 2022-12-14 2024-06-14 Rfc S R L Nuove formulazioni topiche per la stimolazione della crescita dei capelli contenenti forme ossidate di acidi carbossilici a basso peso molecolare
WO2025133708A2 (en) * 2023-12-23 2025-06-26 Specbio, Inc. Therapeutic use of compositions and methods for epidermal treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1216999A (en) * 1968-04-05 1970-12-23 Petrocarbon Dev Ltd Improvements in or relating to the production of percarboxylic acids
US4874361A (en) * 1986-12-29 1989-10-17 Obagi Zein E Method for healing damaged skin
US5166176A (en) * 1986-12-29 1992-11-24 Obagi Zein E Composition for healing damaged skin
US5259888A (en) * 1992-02-03 1993-11-09 Sachem, Inc. Process for cleaning quartz and silicon surfaces
JPH0728192A (ja) * 1993-07-08 1995-01-31 Konica Corp ハロゲン化銀写真感光材料
JP2857042B2 (ja) * 1993-10-19 1999-02-10 新日本製鐵株式会社 シリコン半導体およびシリコン酸化物の洗浄液
JP3040307B2 (ja) * 1994-04-12 2000-05-15 新日本製鐵株式会社 蒸気洗浄方法
IT1274157B (it) 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
EP0806947A4 (en) 1995-02-03 1998-10-14 Cosmederm Technologies FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION
US5827884A (en) * 1995-09-15 1998-10-27 Omp Acquisition Corporation Skin peel maintenance composition and method
US20030026819A1 (en) * 2001-03-09 2003-02-06 Rios Luis A. Cream-to-powder dermatological composition
AU2003278775B2 (en) * 2002-07-01 2010-06-17 Maria Villani Porifera-based therapeutic compositions for treating and preventing skin diseases
US20040101571A1 (en) * 2002-09-11 2004-05-27 Pamela Reed Use of hydrogen peroxide for the treatment of warts
ES2271848T3 (es) * 2003-02-24 2007-04-16 Basf Aktiengesellschaft Polimeros que contienen carboxilato para el tratamiento de superficies metalicas.
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US20060188554A1 (en) * 2003-08-04 2006-08-24 Katashi Nakashima Transdermal absorption preparation
US7465408B1 (en) * 2003-12-03 2008-12-16 Advanced Micro Devices, Inc. Solutions for controlled, selective etching of copper
JP2005281133A (ja) * 2004-03-26 2005-10-13 Shiseido Co Ltd 皮膚外用剤

Also Published As

Publication number Publication date
JP5344926B2 (ja) 2013-11-20
EP1979053B1 (en) 2013-10-23
ES2441440T3 (es) 2014-02-04
US10874883B2 (en) 2020-12-29
SI1979053T1 (sl) 2014-02-28
JP2009519315A (ja) 2009-05-14
WO2007069024A3 (en) 2007-10-04
PT1979053E (pt) 2014-01-07
HRP20140063T1 (hr) 2014-02-28
PL1979053T3 (pl) 2014-04-30
EP1979053A2 (en) 2008-10-15
ITUD20050211A1 (it) 2007-06-14
US20090110646A1 (en) 2009-04-30
AU2006325083B2 (en) 2012-03-15
DK1979053T3 (da) 2014-01-20
WO2007069024A2 (en) 2007-06-21
AU2006325083A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
CY1114888T1 (el) Προϊον για τη θεραπεια του δερματος και των βλεννογονων μεμβρανων, καθως και σχετικη μεθοδος παρασκευης
IL208795A0 (en) Multispecific deimmunized cd3-binders
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MX2010005643A (es) Preparados, metodos y estuches utiles para el tratamiento de la tos.
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
CY1111197T1 (el) Tριαζολες χρησιμες ως αναστολεις πρετεϊνικων κινασων
GB2434983A (en) Methods and compositions for wound healing
SG163600A1 (en) Methods for the treatment of muscle loss
UA106875C2 (uk) Тіадіазолілоксифеніламідини та їх застосування як фунгіцидів
CY1106003T1 (el) Παραγωγα του ν-βενζοϋλοουρεϊδο-κινναμωμικου οξεος, μεθοδος για την παρασκευη τους και η χρηση τους
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
CL2012000374A1 (es) Metodo para la preparacion de una composicion saborizante activa que comprende una primera reaccion entre un compuesto amino y un carbonilo, resultando una primera mezcla de intermediarios, una segunda reaccion con un segundo compuesto amino solo o en combinacion con un compuesto carbinilo, resultando una segunda mezcla de intermediarios, reacciones serparadas adicionales con compuestos de otras clases quimicas, ultima reaccion que comprende una mezcla de todas las mezclas de intermediarios anteriores.
DK1758860T3 (da) Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
CY1106878T1 (el) Παραγωγα πυρρολιδινων και θειαζολιδινων, η μεθοδος παρασκευης τους και η χρηση τους στη θεραπεια της υπεργλυκαιμιας και διαβητη τυπου ii
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
DE602005003654D1 (de) Wasserlösliche tabletten aus natürlichem meersalz in nahrungsmittelqualität und verfahren zu ihrer herstellung
ATE414781T1 (de) Verbessertes verfahren zur herstellung des coenzyms q-10
WO2007079312A3 (en) Compositions and methods for treating actin-mediated medical conditions
EA200701852A1 (ru) Производные аминокислот
NO20033707D0 (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr
NO20033706L (no) Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr